STAT3 and B-cell non-Hodgkin lymphoma: Mutations in STAT3 and (to a lesser extent) STAT5 have been evaluated to be frequently leukemogenic in adults with large granular lymphocyte leukemia, and activating somatic STAT3 mutations have been found in T and B cell lymphomas and chronic lymphoproliferative disorders of NK cells [96,97].